Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine

Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine

Abstract Eptinezumab is a humanized mAb that targets calcitonin gene‐related peptide and is under regulatory review for the prevention of episodic and chronic migraine (EM, CM). It is important to determine whether exposures achieved with intravenous (IV) administration of eptinezumab achieve desire...

Full description

Bibliographic Details
Main Authors: Brian Baker, Barbara Schaeffler, Martin Beliveau, Igor Rubets, Susan Pederson, MyMy Trinh, Jeff Smith, John Latham
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Pharmacology Research & Perspectives
Subjects:
calcitonin gene‐related peptide
CGRP
drug dose‐response relationship
eptinezumab
intravenous administration
migraine disorders
Online Access:https://doi.org/10.1002/prp2.567

Internet

https://doi.org/10.1002/prp2.567

Similar Items